FIGURE

Fig. 10

ID

ZDB-FIG-220719-70

Publication

Bär et al., 2022 - Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer

Other Figures

All Figure Page

Back to All Figure Page

Fig. 10

Effects of different concentrations of bb on the migration of HepG2 cells. HepG2 cell migration was measured using wound healing assays 24 h after treatment. (A) Representative images from five independent experiments, where the cells were treated with at IC₅₀ two-fold IC₅₀ of bb. (B) Cell migration was presented as the mean ± SEM percentage of control from three experiments. One-way ANOVA with Tukey's post hoc test was used to test for significance. ^*P<0.05 and ^**P<0.01 vs. ctrl. ctrl, control; bb, broxbam.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Oncol.